Suggestions
Isabel Najera
Global Head of Infectious Diseases Research, Janssen
Professional Background
Isabel Najera is a highly esteemed professional in the field of infectious diseases, boasting a remarkable career that spans various prestigious organizations and research institutions. Currently serving as the Global Head of Infectious Diseases Research at The Janssen Pharmaceutical Companies of Johnson & Johnson, Isabel has established herself as a leader in the pursuit of innovative solutions to combat infectious diseases, particularly those related to HIV.
Her journey in the world of scientific research began with a solid educational foundation in Chemistry and Biochemistry at the Universidad Complutense de Madrid. This early academic commitment paved the way for her further studies in the field of Biotechnology and Molecular Biology, during which she obtained her MSc at the Universidad Autónoma de Madrid. Isabel's quest for knowledge led her to pursue a Doctor of Philosophy (PhD) under the mentorship of Dr. Esteban Domingo, focusing on genetic variability within HIV at Universidad Complutense de Madrid. Her academic journey reached even greater heights as she engaged in postdoctoral research endeavors in the United Kingdom, where she worked with noted mentors such as Dr. Jonathan Karn and Dr. Brendan Larder at the MRC Laboratory of Molecular Biology and Wellcome Research Laboratories, respectively, honing her expertise in HIV research.
Over the years, Isabel has contributed her extensive knowledge and skills to numerous roles within the pharmaceutical and biotech industries. Prior to her current position at Janssen, Isabel served in several impactful roles at Roche, where she was pivotal in various research and development capacities focusing on infectious diseases and virology. As the Senior Director and Head of Discovery and Clinical Virology at Roche, Isabel's leadership not only directed the strategic research initiatives but also facilitated groundbreaking advancements in the understanding and treatment of viral infections.
Education and Achievements
Isabel Najera's educational achievements reflect her commitment to advancing her knowledge in the sciences. Having completed her BSc (Hons) in Chemistry and Biochemistry, she progressed to pursue an MSc in Biotechnology and Molecular Biology. This academic trajectory culminated in her PhD, upon which she specialized in the genetic variability of HIV.
In her postdoctoral journeys in the UK, Isabel gained invaluable practical experience, emphasizing her interest in HIV and its complexities. With an entrenched understanding of molecular biology and hands-on laboratory expertise, Isabel has continually pushed the envelope in research, leading to her esteemed position at Johnson & Johnson today.
Notable Achievements
Throughout her impressive career, Isabel Najera has amassed an array of notable achievements that underscore her expertise and contributions to the field of infectious diseases.
- Innovative Research: At Roche, she spearheaded numerous projects focusing on drug resistance monitoring, showcasing her dedication to overcoming the challenges of viral infections.
- Leadership Initiatives: Isabel has led teams of dedicated scientists in discovering new therapeutic approaches, with a focus on enhancing the efficacy of treatments for infectious diseases.
- Consultation and Collaboration: Her role as an independent consultant has allowed her to share her insights and foster collaborations across various organizations, thus amplifying the impact of her research findings.
- Mentorship and Influence: Isabel is not only a visionary in her research, but she is also committed to mentoring the next generation of scientists, sharing her knowledge and passion for infectious disease research.
title
Isabel Najera's Background: A Leader in Infectious Diseases Research